eResearchTechnology, Inc.

$1.7M awarded to study cardiac safety monitoring

Published in Telemedicine Law Weekly, July 17th, 2004

eResearchTechnology, Inc., (eRT, ERES), a leading provider of centralized electrocardiographic (ECG) collection and interpretation services, announced that it has received an agreement for about $1.7 million in cardiac safety monitoring and services from an emerging pharmaceutical organization for one of its drug candidates in clinical development.

The agreement covers an extensive phase I study for which eRT is providing comprehensive support including the provision, training and ongoing assistance required for effective use of digital 12-lead Holter equipment designed to facilitate 24-hour digital recording of cardiac safety data that is subsequently provided to eRT...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Telemedicine Law Weekly

Source: Telemedicine Law Weekly (2004-07-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry